Radiology:超声评判的BI-RADS等级也可能不是那么准!

2018-05-21 shaosai MedSci原创

本研究旨在评价光声(OA)超声(US)在准确评价原BI-RADS为4a和4b的乳腺良性肿块降级为3或2的价值,并将结果发表在Radiology上。

本研究旨在评价光声(OA)超声(US)在准确评价原BI-RADS为4a和4b的乳腺良性肿块降级为3或2的价值,并将结果发表在Radiology上。

本研究旨在利用OA/US技术中激光来测量可疑乳腺肿块周围的含氧血红蛋白及脱氧血红蛋白的相对数量。本研究共纳入了209例患者,共有215处病变被US评为BI-RADS 4a或4b。根据临床病史及影像学表现,通过US对肿块进行首次评价,然后根据基于US信息恶性可能性和BI-RADS分类进行评价每一处肿块。随后利用OA/US对肿块进行再次评价。在OA/US评价过程中,放射科医生对5个OA/US特征进行评分,然后进行基于OA/US的POM和BI-RADS分类中。利用5个OA特征评分的加权数量评价OA/US BI-RADS降级或升级的百分比。

结果为,在OA/US中,共有47.9% (57/119; 95% CI: 0.39, 0.57) BI-RADS 4a和11.1% (3/27; 95% CI: 0.03, 0.28) BI-RADS 4b的乳腺肿块被降级为BI-RADS 3或2。2/7处原US为BI-RADS 4a恶性肿瘤被错误地降级,1/60处原US为BI-RADS 4b恶性肿瘤被错误地降级,整体假阴性为4.5% (3/67; 95% CI: 0.01, 0.13)。

本研究表明,通过OA/US,US评为BI-RADS 4a的乳腺肿块可被降级,这便能减少肿瘤的活检阴性率以及短期随访频率,而有少数可能会被错误地降级。

原始出处:

Menezes GLG, Pijnappel RM, Meeuwis C. et al.Downgrading of Breast Masses Suspicious for Cancer by Using Optoacoustic Breast Imaging.Radiology.DOI:10.1148/radiol.2018170500

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1792984, encodeId=710f1e9298410, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Thu Jan 31 10:34:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029511, encodeId=77a02029511a7, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Sat Jul 21 10:34:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320207, encodeId=3dd032020e16, content=张知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ebf2171208, createdName=wuyonggen, createdTime=Thu May 31 07:55:45 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319071, encodeId=95ee3190e190, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKrxzVuKWm8d34VdNGyVr1iampV9wMjh4cS7LapkP4nfiaHqibPcju0ZhQqnurr2wXribjiaRZQ4x8OiaQw/132, createdBy=462d2336119, createdName=王芳芳364, createdTime=Sun May 27 14:28:24 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479628, encodeId=d8aa14e962860, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Wed May 23 02:34:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317226, encodeId=084131e226e7, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon May 21 13:18:38 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317223, encodeId=e7d831e223ef, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Mon May 21 12:12:30 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2019-01-31 江川靖瑶
  2. [GetPortalCommentsPageByObjectIdResponse(id=1792984, encodeId=710f1e9298410, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Thu Jan 31 10:34:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029511, encodeId=77a02029511a7, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Sat Jul 21 10:34:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320207, encodeId=3dd032020e16, content=张知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ebf2171208, createdName=wuyonggen, createdTime=Thu May 31 07:55:45 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319071, encodeId=95ee3190e190, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKrxzVuKWm8d34VdNGyVr1iampV9wMjh4cS7LapkP4nfiaHqibPcju0ZhQqnurr2wXribjiaRZQ4x8OiaQw/132, createdBy=462d2336119, createdName=王芳芳364, createdTime=Sun May 27 14:28:24 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479628, encodeId=d8aa14e962860, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Wed May 23 02:34:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317226, encodeId=084131e226e7, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon May 21 13:18:38 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317223, encodeId=e7d831e223ef, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Mon May 21 12:12:30 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1792984, encodeId=710f1e9298410, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Thu Jan 31 10:34:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029511, encodeId=77a02029511a7, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Sat Jul 21 10:34:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320207, encodeId=3dd032020e16, content=张知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ebf2171208, createdName=wuyonggen, createdTime=Thu May 31 07:55:45 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319071, encodeId=95ee3190e190, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKrxzVuKWm8d34VdNGyVr1iampV9wMjh4cS7LapkP4nfiaHqibPcju0ZhQqnurr2wXribjiaRZQ4x8OiaQw/132, createdBy=462d2336119, createdName=王芳芳364, createdTime=Sun May 27 14:28:24 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479628, encodeId=d8aa14e962860, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Wed May 23 02:34:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317226, encodeId=084131e226e7, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon May 21 13:18:38 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317223, encodeId=e7d831e223ef, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Mon May 21 12:12:30 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2018-05-31 wuyonggen

    张知识了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1792984, encodeId=710f1e9298410, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Thu Jan 31 10:34:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029511, encodeId=77a02029511a7, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Sat Jul 21 10:34:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320207, encodeId=3dd032020e16, content=张知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ebf2171208, createdName=wuyonggen, createdTime=Thu May 31 07:55:45 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319071, encodeId=95ee3190e190, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKrxzVuKWm8d34VdNGyVr1iampV9wMjh4cS7LapkP4nfiaHqibPcju0ZhQqnurr2wXribjiaRZQ4x8OiaQw/132, createdBy=462d2336119, createdName=王芳芳364, createdTime=Sun May 27 14:28:24 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479628, encodeId=d8aa14e962860, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Wed May 23 02:34:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317226, encodeId=084131e226e7, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon May 21 13:18:38 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317223, encodeId=e7d831e223ef, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Mon May 21 12:12:30 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2018-05-27 王芳芳364

    学习了.谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1792984, encodeId=710f1e9298410, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Thu Jan 31 10:34:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029511, encodeId=77a02029511a7, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Sat Jul 21 10:34:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320207, encodeId=3dd032020e16, content=张知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ebf2171208, createdName=wuyonggen, createdTime=Thu May 31 07:55:45 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319071, encodeId=95ee3190e190, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKrxzVuKWm8d34VdNGyVr1iampV9wMjh4cS7LapkP4nfiaHqibPcju0ZhQqnurr2wXribjiaRZQ4x8OiaQw/132, createdBy=462d2336119, createdName=王芳芳364, createdTime=Sun May 27 14:28:24 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479628, encodeId=d8aa14e962860, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Wed May 23 02:34:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317226, encodeId=084131e226e7, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon May 21 13:18:38 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317223, encodeId=e7d831e223ef, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Mon May 21 12:12:30 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1792984, encodeId=710f1e9298410, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Thu Jan 31 10:34:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029511, encodeId=77a02029511a7, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Sat Jul 21 10:34:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320207, encodeId=3dd032020e16, content=张知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ebf2171208, createdName=wuyonggen, createdTime=Thu May 31 07:55:45 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319071, encodeId=95ee3190e190, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKrxzVuKWm8d34VdNGyVr1iampV9wMjh4cS7LapkP4nfiaHqibPcju0ZhQqnurr2wXribjiaRZQ4x8OiaQw/132, createdBy=462d2336119, createdName=王芳芳364, createdTime=Sun May 27 14:28:24 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479628, encodeId=d8aa14e962860, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Wed May 23 02:34:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317226, encodeId=084131e226e7, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon May 21 13:18:38 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317223, encodeId=e7d831e223ef, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Mon May 21 12:12:30 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2018-05-21 1ddf0692m34(暂无匿称)

    学习了.长知识

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1792984, encodeId=710f1e9298410, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Thu Jan 31 10:34:00 CST 2019, time=2019-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029511, encodeId=77a02029511a7, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Sat Jul 21 10:34:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320207, encodeId=3dd032020e16, content=张知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ebf2171208, createdName=wuyonggen, createdTime=Thu May 31 07:55:45 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319071, encodeId=95ee3190e190, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKrxzVuKWm8d34VdNGyVr1iampV9wMjh4cS7LapkP4nfiaHqibPcju0ZhQqnurr2wXribjiaRZQ4x8OiaQw/132, createdBy=462d2336119, createdName=王芳芳364, createdTime=Sun May 27 14:28:24 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479628, encodeId=d8aa14e962860, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Wed May 23 02:34:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317226, encodeId=084131e226e7, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon May 21 13:18:38 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317223, encodeId=e7d831e223ef, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Mon May 21 12:12:30 CST 2018, time=2018-05-21, status=1, ipAttribution=)]
    2018-05-21 lietome2

    好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛.

    0

相关资讯

Eur Radiol:3D ABUS与HHUS在乳腺癌病变和BI-RADS特征显示的价值

现在,很多医院的乳腺钼靶片、B超检查和磁共振检查报告诊断为乳腺改变BI-RADS多少级,引起一些女性的无谓紧张,认为2级、3级就是癌症可能的2期、3期。其实,BI-RADS(Breast imaging reporting and data system)即美国放射学会推荐的"乳腺影像报告和数据系统"。本研究旨在评价自动乳腺超声(ABUS)与手持传统超声(HHUS)在显示乳腺病变和BI-RADS特

Radiology:除了你所熟知的BI-RADS,鉴别乳腺良恶性还能依靠其他非侵入性方法吗?

本研究旨在探究联合体素内不相关运动(IVIM)与非高斯扩散参数方法在评价多参数阈值评分或可能性来鉴别良恶性乳腺病变的价值及其与分子预后指标的相关性,并将结果发表在Radiology上。

Radiology: BI-RADS分类耳熟能详, 那亚分类呢?

为了验证ACR和BI-RADS 4分类在诊断学乳房X摄影的应用和阳性预测值(PPV)的价值,并将结果发表在Radiology上。